A packaging error has prompted generic drugmaker Qualitest Pharmaceuticals to recall multiple lots of oral contraceptives. Medscape Medical News
No Comments »
Filed under: General Health News
Prescription opioids, sedative-hypnotics, and cardiovascular drugs are driving an overall increase in pharmaceutical poisoning of children aged 5 years and younger. Medscape Medical News
No Comments »
Filed under: General Health News
Six letters appearing in JAMA this week criticize a controversial study from Belgium published earlier this year that concluded that sodium reduction would likely not be beneficial for the general population. Heartwire
No Comments »
Filed under: General Health News
(MedPage Today) — Generic drugmaker Qualitest Pharmaceuticals pulled several lots of a number of oral contraceptives due to a packaging error that obscured the products’ lot number and expiration date.
No Comments »
Filed under: General Health News
(MedPage Today) — A federal judge invalidated the Affordable Care Act’s individual mandate and the government finalized a new program to fight Medicaid fraud, among other events this week.
No Comments »
Filed under: General Health News
(MedPage Today) — It’s common to see physicians and nurses outside hospitals in scrubs replete with dangling stethoscopes, but MedPage Today readers want that to end.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson’s disease, Alzheimer’s disease, and a number of other neurological disorders.
No Comments »
Filed under: General Health News
(MedPage Today) — Generic drugmaker Qualitest Pharmaceuticals pulled several lots of a number of oral contraceptives due to a packaging error that obscured the products’ lot number and expiration date.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson’s disease, Alzheimer’s disease, and a number of other neurological disorders.
No Comments »
Filed under: Pharmacy News
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
No Comments »
Filed under: Pharmacy News
